Abeona Therapeutics Files 8-K on Security Holder Vote
Ticker: ABEO · Form: 8-K · Filed: May 19, 2025 · CIK: 318306
| Field | Detail |
|---|---|
| Company | Abeona Therapeutics Inc. (ABEO) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
ABEONA filed an 8-K about a shareholder vote. Details TBD.
AI Summary
On May 19, 2025, Abeona Therapeutics Inc. filed an 8-K report indicating that it submitted matters to a vote of its security holders. The filing does not specify the nature of the matters or the outcome of the vote.
Why It Matters
This filing signals that Abeona Therapeutics is engaging its shareholders on important corporate decisions, which could impact future strategic direction or governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Abeona Therapeutics Inc. (company) — Registrant
- May 19, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Abeona Therapeutics' security holders?
The filing does not specify the exact matters that were submitted for a vote.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 19, 2025.
What is the principal executive office address for Abeona Therapeutics Inc.?
The address is 6555 Carnegie Ave, 4th Floor, Cleveland, OH 44103.
What is Abeona Therapeutics Inc.'s Commission File Number?
The Commission File Number is 001-15771.
What is the Standard Industrial Classification code for Abeona Therapeutics Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding ABEONA THERAPEUTICS INC. (ABEO).